Inhibition of tumor progression using antisense oligonucleotide targeting Gli2 in androgen independent prostate cancer

被引：0
|
作者：
Narita, Shintaro
So, Alan I.
Sinnemann, Shannon
Fazli, Ladan
Marcusson, Eric G.
Gleave, Martin E.
机构：
来源：
JOURNAL OF UROLOGY | 2007年 / 177卷 / 04期
关键词：
D O I：
10.1016/S0022-5347(18)30415-4
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：51 / 51
页数：1
相关论文
共 50 条
  • [1] Targeting prostate cancer with next generation antisense oligonucleotide against androgen receptor and AKT inhibition
    Sugimoto, Kouichi
    De Velasco, Marco A.
    Kura, Yurie
    Sakai, Kazuko
    Nozawa, Masahiro
    Yoshimura, Kazuhiro
    Yoshikawa, Kazuhiro
    Nishio, Kazuto
    Uemura, Hirotsugu
    CANCER SCIENCE, 2018, 109 : 357 - 357
  • [2] Role of Gli2 in mediating the progression of prostate cancer to CRPC
    Xia, Lu
    Qin, Tai
    Sun, Luzhe
    CANCER RESEARCH, 2016, 76
  • [3] Inhibition of mouse PTEN-deficient prostate cancer with next generation antisense oligonucleotide targeting the androgen receptor
    De Velasco, Marco A.
    Kura, Yurie
    Ando, Naomi
    Fukushima, Emiko
    Davies, Barry R.
    Campbell, Hayley
    Hatanaka, Yuji
    Yamamoto, Yutaka
    Shimizu, Nobutaka
    Nozawa, Masahiro
    Yoshimura, Kazuhiro
    Yoshikawa, Kazuhiro
    Nishio, Kazuto
    Uemura, Hirotsugu
    CANCER RESEARCH, 2015, 75
  • [4] Inhibition of GLI2 with antisense-oligonucleotides: A potential therapy for the treatment of bladder cancer
    Raven, Peter A.
    Lysakowski, Summer
    Tan, Zheng
    D'Costa, Ninadh M.
    Moskalev, Igor
    Frees, Sebastian
    Struss, Werner
    Matsui, Yoshiyuki
    Narita, Shintaro
    Buttyan, Ralph
    Chavez-Munoz, Claudia
    So, Alan I.
    JOURNAL OF CELLULAR PHYSIOLOGY, 2019, 234 (11) : 20634 - 20647
  • [5] Targeting castration-resistant prostate cancer with androgen receptor antisense oligonucleotide therapy
    De Velasco, Marco A.
    Kura, Yurie
    Sakai, Kazuko
    Hatanaka, Yuji
    Davies, Barry R.
    Campbell, Hayley
    Klein, Stephanie
    Kim, Youngsoo
    MacLeod, A. Robert
    Sugimoto, Koichi
    Yoshikawa, Kazuhiro
    Nishio, Kazuto
    Uemura, Hirotsugu
    JCI INSIGHT, 2019, 4 (17)
  • [6] Targeting bcl-2 gene to delay androgen-independent progression and enhance chemosensitivity in prostate cancer using antisense bcl-2 oligodeoxynucleotides
    Gleave, ME
    Miayake, H
    Goldie, J
    Nelson, C
    Tolcher, A
    UROLOGY, 1999, 54 (6A) : 36 - 46
  • [7] Telomerase inhibition prevents androgen independent osseous prostate cancer progression
    Li, YM
    Thompson, M
    Chen, Z
    Malaeb, BS
    Corey, D
    Shay, J
    Koeneman, KS
    JOURNAL OF UROLOGY, 2005, 173 (04): : 126 - 127
  • [8] Inhibition of LNCaP prostate tumor growth in vivo by an antisense oligonucleotide directed against the human androgen receptor
    Eder, IE
    Hoffmann, J
    Rogatsch, H
    Schäfer, G
    Zopf, D
    Bartsch, G
    Klocker, H
    CANCER GENE THERAPY, 2002, 9 (02) : 117 - 125
  • [9] Inhibition of LNCaP prostate tumor growth in vivo by an antisense oligonucleotide directed against the human androgen receptor
    Iris E Eder
    Jens Hoffmann
    Hermann Rogatsch
    Georg Schäfer
    Dieter Zopf
    Georg Bartsch
    Helmut Klocker
    Cancer Gene Therapy, 2002, 9 : 117 - 125
  • [10] Erratum: Inhibition of LNCaP prostate tumor growth in vivo by an antisense oligonucleotide directed against the human androgen receptor
    I E Eder
    J Hoffmann
    H Rogatsch
    G Schäfer
    D Zopf
    G Bartsch
    H Klocker
    Cancer Gene Therapy, 2007, 14 : 934 - 934
12345